Dr Reddy's and GSK alliance...................

As stated by me on 14th June blog about Reddy's alliance with some european pharma giants, the news is Dr Reddy's and GSK signed a deal which gives GSK exclusive access to Dr. Reddy's portfolio and pipeline of more than 100 branded pharmaceuticals in segments including cardiovascular, diabetes, oncology, gastroenterology and pain management, wherein these products will be manufactured by Dr. Reddy's and licensed and supplied by Glaxo in countries in Africa, Middle East, Asia Pacific and Latin America. In certain markets, products will be co-marketed by GlaxoSmithKline and Dr. Reddy's.

After Pfizer in US it is Glaxo in Europe which is aggresively closing deals.......................